ResMed sells its MatrixCare software business to Frazier for $490m
AI Today Summary
ResMed has sold its MatrixCare home-health and senior-care software business to private equity firm Frazier Healthcare Partners for $490 million in cash. The sale allows ResMed to focus on its core medical-device business, particularly in sleep and breathing health, while Frazier acquires a profitable software provider in the growing home and post-acute care market. ResMed plans to use the proceeds to return capital to shareholders and support its strategic focus on hardware and connected care.
Covered by 1 source
AI Today publishes original summaries and links out — never the full source article.